Cargando…

Experimental solubility and thermodynamic modeling of empagliflozin in supercritical carbon dioxide

The solubility of empagliflozin in supercritical carbon dioxide was measured at temperatures (308 to 338 K) and pressures (12 to 27 MPa), for the first time. The measured solubility in terms of mole faction ranged from 5.14 × 10(–6) to 25.9 × 10(–6). The cross over region was observed at 16.5 MPa. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Sodeifian, Gholamhossein, Garlapati, Chandrasekhar, Razmimanesh, Fariba, Nateghi, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151729/
https://www.ncbi.nlm.nih.gov/pubmed/35637271
http://dx.doi.org/10.1038/s41598-022-12769-2
_version_ 1784717533425696768
author Sodeifian, Gholamhossein
Garlapati, Chandrasekhar
Razmimanesh, Fariba
Nateghi, Hassan
author_facet Sodeifian, Gholamhossein
Garlapati, Chandrasekhar
Razmimanesh, Fariba
Nateghi, Hassan
author_sort Sodeifian, Gholamhossein
collection PubMed
description The solubility of empagliflozin in supercritical carbon dioxide was measured at temperatures (308 to 338 K) and pressures (12 to 27 MPa), for the first time. The measured solubility in terms of mole faction ranged from 5.14 × 10(–6) to 25.9 × 10(–6). The cross over region was observed at 16.5 MPa. A new solubility model was derived to correlate the solubility data using solid–liquid equilibrium criteria combined with Wilson activity coefficient model at infinite dilution for the activity coefficient. The proposed model correlated the data with average absolute relative deviation (AARD) and Akaike’s information criterion (AIC(c)), 7.22% and − 637.24, respectively. Further, the measured data was also correlated with 11 existing (three, five and six parameters empirical and semi-empirical) models and also with Redlich-Kwong equation of state (RKEoS) along with Kwak-Mansoori mixing rules (KMmr) model. Among density-based models, Bian et al., model was the best and corresponding AARD% was calculated 5.1. The RKEoS + KMmr was observed to correlate the data with 8.07% (correspond AIC(c) is − 635.79). Finally, total, sublimation and solvation enthalpies of empagliflozin were calculated.
format Online
Article
Text
id pubmed-9151729
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-91517292022-06-01 Experimental solubility and thermodynamic modeling of empagliflozin in supercritical carbon dioxide Sodeifian, Gholamhossein Garlapati, Chandrasekhar Razmimanesh, Fariba Nateghi, Hassan Sci Rep Article The solubility of empagliflozin in supercritical carbon dioxide was measured at temperatures (308 to 338 K) and pressures (12 to 27 MPa), for the first time. The measured solubility in terms of mole faction ranged from 5.14 × 10(–6) to 25.9 × 10(–6). The cross over region was observed at 16.5 MPa. A new solubility model was derived to correlate the solubility data using solid–liquid equilibrium criteria combined with Wilson activity coefficient model at infinite dilution for the activity coefficient. The proposed model correlated the data with average absolute relative deviation (AARD) and Akaike’s information criterion (AIC(c)), 7.22% and − 637.24, respectively. Further, the measured data was also correlated with 11 existing (three, five and six parameters empirical and semi-empirical) models and also with Redlich-Kwong equation of state (RKEoS) along with Kwak-Mansoori mixing rules (KMmr) model. Among density-based models, Bian et al., model was the best and corresponding AARD% was calculated 5.1. The RKEoS + KMmr was observed to correlate the data with 8.07% (correspond AIC(c) is − 635.79). Finally, total, sublimation and solvation enthalpies of empagliflozin were calculated. Nature Publishing Group UK 2022-05-30 /pmc/articles/PMC9151729/ /pubmed/35637271 http://dx.doi.org/10.1038/s41598-022-12769-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Sodeifian, Gholamhossein
Garlapati, Chandrasekhar
Razmimanesh, Fariba
Nateghi, Hassan
Experimental solubility and thermodynamic modeling of empagliflozin in supercritical carbon dioxide
title Experimental solubility and thermodynamic modeling of empagliflozin in supercritical carbon dioxide
title_full Experimental solubility and thermodynamic modeling of empagliflozin in supercritical carbon dioxide
title_fullStr Experimental solubility and thermodynamic modeling of empagliflozin in supercritical carbon dioxide
title_full_unstemmed Experimental solubility and thermodynamic modeling of empagliflozin in supercritical carbon dioxide
title_short Experimental solubility and thermodynamic modeling of empagliflozin in supercritical carbon dioxide
title_sort experimental solubility and thermodynamic modeling of empagliflozin in supercritical carbon dioxide
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151729/
https://www.ncbi.nlm.nih.gov/pubmed/35637271
http://dx.doi.org/10.1038/s41598-022-12769-2
work_keys_str_mv AT sodeifiangholamhossein experimentalsolubilityandthermodynamicmodelingofempagliflozininsupercriticalcarbondioxide
AT garlapatichandrasekhar experimentalsolubilityandthermodynamicmodelingofempagliflozininsupercriticalcarbondioxide
AT razmimaneshfariba experimentalsolubilityandthermodynamicmodelingofempagliflozininsupercriticalcarbondioxide
AT nateghihassan experimentalsolubilityandthermodynamicmodelingofempagliflozininsupercriticalcarbondioxide